Atlas Trials

Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance

Clinical trial NCT01295333 · COMPLETED

Trial details

NCT number
NCT01295333
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Graves Disease (Basedow's Disease)
Start date
2011-05-01
Primary completion
2014-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.